Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The gut microbiota has emerged as a significant biomarker for predicting how patients with Melanoma (cutaneous) will respond to treatment. Researchers are actively exploring various strategies to alter the microbiome in order to improve patient outcomes (1).
It is an open label phase I treatment trial (Single Group Assignment) evaluating Fecal Microbial Transplantation (FMT) + Nivolumab vs Fecal Microbiota Transplantation (FMT) + Pembrolizumab in 20 recruited patients with metastatic [Melanoma (cutaneous)](brain://PB0YkuSZCkK…